Search
Now showing items 1-10 of 387
Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.
(The Cochrane Collaboration., 2013)
The primary objective of this review was to evaluate the antiviral efficacy of co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection. The secondary objectives were to evaluate the safety and ...
Bigotry and oppressive laws in Africa drive HIV in men who have sex with men.
(Plos., 2013)
No abstract available.
Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.
(Elsevier., 2011)
Background. Nevirapine given once-daily for the first 6, 14, or 28 weeks of life to infants exposed to HIV-1
via breastfeeding reduces transmission through this route compared with single-dose nevirapine at birth or ...
Immune evaluation of HIV-infected and noninfected pre-eclamptics.
(MedPharm, 2009)
No abstract available.
Microbicides & their implications in HIV prevention.
(MedKnow Publications., 2010)
No abstract available.
Community-based intervention is necessary for the control of HIV in North-Central Nigeria.
(Elsevier., 2011)
Objectives: To determine factors associated with the observed high prevalence of HIV in North-Central Nigeria.
Methods: In a cross-sectional multisite study conducted in 2007, behavioral, medical, and demographic data ...
Effects of a reduced dose of Stavudine on the incidence and severity of peripheral neuropathy in HIV-infected adults in South Africa.
(International Medical Press., 2011)
BACKGROUND—Although recent WHO guidelines recommend withdrawing stavudine (d4T) from first-line ART therapy, it remains commonly used in resource-constrained settings. In 2006, WHO recommended decreasing the dose of d4T ...
Why human health and health ethics must be central to climate change deliberations.
(Plos., 2012)
No abstract available.
Overview of microbicides for the prevention of human immunodeficiency virus.
(Elsevier., 2012)
Human immunodeficiency virus (HIV) prevention tools that women can use and control are urgently needed. Microbicides are chemical products applied to the vagina or rectum to prevent the sexual transmission of HIV. Four ...
A community officer’s perspective of a rural hospital in KwaZulu-Natal.
(South African Medical Association / Health & Medical Publications Group., 2012)
No abstract available.